Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	DOTS Control Group	32
Overall Study	STARTED	Aerosol Interferon Gamma for TB	32
Overall Study	STARTED	Subcutaneous Interferon Gamma for TB	32
Overall Study	Did Not Meet Continuation Criteria	DOTS Control Group	2
Overall Study	Did Not Meet Continuation Criteria	Aerosol Interferon Gamma for TB	0
Overall Study	Did Not Meet Continuation Criteria	Subcutaneous Interferon Gamma for TB	5
Overall Study	COMPLETED	DOTS Control Group	26
Overall Study	COMPLETED	Aerosol Interferon Gamma for TB	28
Overall Study	COMPLETED	Subcutaneous Interferon Gamma for TB	23
Overall Study	NOT COMPLETED	DOTS Control Group	6
Overall Study	NOT COMPLETED	Aerosol Interferon Gamma for TB	4
Overall Study	NOT COMPLETED	Subcutaneous Interferon Gamma for TB	9

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00201123/flow